Hypertrophic cardiomyopathy is a disease in which the thickness of the heart wall increases significantly. A particular danger is the so-called asymmetric form of the disease, when the myocardium of the left ventricular outflow tract thickens to a greater extent, there is an obstacle to the exit of blood, and the operation of the valve apparatus is disrupted. Hypertrophic cardiomyopathy can also negatively affect the state of the cardiac conduction system, up to the development of life-threatening conditions (arrhythmias)

Symptoms include the following:

1. shortness of breath, especially during exercise or exertion;
2. chest pain, especially during exercise;
3. fainting, especially during exercise;
4. dizziness;
5. fatigue;
6. rapid heartbeat.

Treatment of the disease is only surgical.

Transcatheter alcoholic septal ablation is a minimally invasive procedure that reduces the thickness of the septum between the ventricles. This occurs as a result of the introduction of ethyl alcohol through a balloon catheter into one or more septal branches of the anterior interventricular branch of the left coronary artery. The result is controlled myocardial necrosis in a limited area of ​​the interventricular septum. The work of the heart muscle is restored in this way.

Septal alcohol ablation differs from surgery in that there is no need to open the patient’s chest. For a minimally invasive procedure, local anesthesia is used. At the same time, the terms of treatment and rehabilitation are significantly reduced, there is no need for a long stay in the hospital.